Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial

Peer Review reports

Original Submission
12 Apr 2023	Submitted	Original manuscript
11 Aug 2023	Reviewed	Reviewer Report
6 Sep 2023	Reviewed	Reviewer Report - Shebli Atrash
26 Sep 2023	Author responded	Author comments - Wenming Chen
Resubmission - Version 2
26 Sep 2023	Submitted	Manuscript version 2
29 Sep 2023	Reviewed	Reviewer Report - Shebli Atrash
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
8 Oct 2023	Editorially accepted
14 Oct 2023	Article published	10.1186/s12885-023-11489-8

Back to article page